Knee stem cell injection gains attention as innovative treatment

Autologous bone marrow stem cell therapy (BMAC Knee Mother’s Coma) In the case of knee, it has recently gained recognition as innovative treatment, showing significant effectiveness in the treatment of osteoarthritis.

Eight BMAC (무릎줄기세포주사) injection studies, which was officially approved as a new medical technology in South Korea last year, showed its effectiveness in relieving degenerative pain of the knee joints. In cases of arthritis from early to medium joint, 94.4% of patients have experienced significant alleviation of pain.

A typical treatment process of degenerative knee joints begins with non -surgical methods of treating pain. A knee exchange surgery is often required as progressed. Since effective pain control can significantly delay the need for surgery, continuous tests were carried out to develop new therapies – which are distinguished by BMAC injections.

Earlier corticosteroid injections were usually prescribed to treat pain of arthritis. However, recent studies have shown that steroid injections can actually accelerate joint degeneration.

Skans MRI patients with arthritis have shown that people who received steroid injections experienced faster deterioration of cartilage and surrounding tissues.

Scientists warn that although steroid injections can ensure short -term relief of pain, they can promote long -term knee tissue damage. In particular, increased cartilage degeneration and inflammation were observed.

As a result, medical experts are now calling for patients who have been prescribed steroid injections due to pain of knee arthritis to consider alternative, safer and more effective treatment options such as BMAC (BMAC (Knee) Therapy.

Dr. Yeong-Seok Lee, director Saint Luke hospitalHe said: “If knee pain is hard enough to disturb everyday life, it may indicate that this condition has already developed. The key is to search for a specialist diagnosis as early as possible.”